SelSym Biotech’s lead product, SymClot, mimics platelet functions to augment hemorrhage control in trauma and surgery and helps to address critical ongoing platelet supply shortages and shelf life limitations
Addressing critical unmet needs in bleeding management
Healing
Unique mechanism of action supports and improves overall wound healing outcomes after cessation of bleeding
REVOLUTIONIZING HEMORRHAGE CONTROL
SymClot: A Novel Therapy to Control Bleeding
PLATFORM TECHNOLOGY
Hemostatic Healing Hydrogels (H3)
SelSym Biotech’s suite of Hemostatic Healing Hydrogels (H3) can be easily tuned to address a wide range of clinical needs in bleeding management and wound healing, including hemorrhage control, drug delivery, infection control, and long-term healing support for chronic wounds
Illustrations created using BioRender.com